← ICU MEDICAL INC/DE ICUI
Market Price
$182.93
Market Cap
$4.58B
P/E Ratio
6,097.50
Revenue (FY 2025)
↓-6.3% YoY
$2.23B
3-Yr CAGR: -0.7%
Net Income
↑100.6% YoY
$732.00K
Net Margin: 0.0%
Free Cash Flow
↓-26.4% YoY
$91.80M
FCF Yield: 2.01%
EPS (Diluted)
↑100.6% YoY
$0.03
Basic: $0.03
Return on Equity
Efficiency
0.0%
ROA: 0.8%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ICUI)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $379.4M | — | $201.4M | $63.1M | — | $3.66 | — | $89.9M | $66.6M | — |
| FY 2017 | $1,292.6M | +240.7% | $426.1M | $68.6M | +8.8% | $3.29 | -10.1% | $154.4M | $79.9M | +20.1% |
| FY 2018 | $1,400.0M | +8.3% | $570.0M | $28.8M | -58.1% | $1.33 | -59.6% | $160.2M | $67.5M | -15.6% |
| FY 2019 | $1,266.2M | -9.6% | $471.9M | $101.0M | +250.9% | $4.69 | +252.6% | $101.9M | $4.6M | -93.2% |
| FY 2020 | $1,271.0M | +0.4% | $461.5M | $86.9M | -14.0% | $4.02 | -14.3% | $222.8M | $130.7M | +2,738.6% |
| FY 2021 | $1,316.3M | +3.6% | $491.5M | $103.1M | +18.7% | $4.74 | +17.9% | $267.5M | $199.0M | +52.2% |
| FY 2022 | $2,280.0M | +73.2% | $697.8M | $-74.3M | -172.0% | $-3.11 | -165.6% | $-62.1M | $-152.4M | -176.6% |
| FY 2023 | $2,259.1M | -0.9% | $739.9M | $-29.7M | +60.1% | $-1.23 | +60.5% | $166.2M | $82.3M | +154.0% |
| FY 2024 | $2,382.0M | +5.4% | $824.8M | $-117.7M | -296.9% | $-4.83 | -292.7% | $204.0M | $124.7M | +51.5% |
| FY 2025 | $2,231.3M | -6.3% | $822.0M | $0.7M | +100.6% | $0.03 | +100.6% | $179.8M | $91.8M | -26.4% |
Valuation
Market Price
$182.93
Market Cap
$4.58B
Enterprise Value
$5.65B
P/E Ratio
6,097.50
P/B Ratio
2.15
FCF Yield
2.01%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
36.84%
Operating Margin
1.92%
Net Margin
0.03%
Return on Equity (ROE)
0.03%
Return on Assets (ROA)
0.85%
Asset Turnover
25.88x
Revenue 3-Yr CAGR
-0.72%
Financial Health & Liquidity
Current Ratio
0.27
Cash Ratio
0.66
Debt / Equity
0.605
Debt / Assets
14.900
Cash & Equivalents
$208.78M
Total Debt
$1.28B
Book Value / Share
$84.97
Cash Flow Efficiency
Operating Cash Flow
$179.85M
Capital Expenditures (CapEx)
$88.04M
Free Cash Flow
$91.80M
OCF / Revenue
8.06%
FCF / Revenue
4.11%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$0.03
EPS (Basic)
$0.03
Dividends / Share
N/A
Book Value / Share
$84.97
EPS YoY Growth
100.62%
Balance Sheet (FY 2025)
Total Assets
$86.22M
Total Liabilities
$315.34M
Stockholders' Equity
$2.12B
Current Assets
$86.22M
Current Liabilities
$315.34M